Related Experiment Video
Updated: Sep 28, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Toll-Like Receptor 3 in Cardiovascular Diseases
Chunying Zhuang1, Riken Chen2, Zhenzhen Zheng3
1China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; First Clinical School, Guangzhou Medical University, Guangzhou, China.
Toll-like receptor 3 (TLR3) plays a key role in innate immunity and cardiovascular diseases (CVDs). Research explores how TLR3 influences CVDs, highlighting its potential as an immunomodulator for future treatments.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Molecular Biology
Background:
- Toll-like receptor 3 (TLR3) is a critical component of the innate immune system.
- TLR3 activation by molecular patterns contributes to inflammatory diseases.
- Its role in cardiovascular diseases (CVDs) is increasingly recognized.
Purpose of the Study:
- To review current research on TLR3 in the context of cardiovascular diseases.
- To elucidate the mechanisms by which TLR3 contributes to CVD pathogenesis.
- To discuss the therapeutic potential of TLR3 modulation in CVDs.
Main Methods:
- Literature review of recent studies on TLR3 and CVDs.
- Analysis of molecular and cellular mechanisms linking TLR3 to cardiovascular pathology.
- Synthesis of findings regarding TLR3's role in various cardiovascular conditions.
Main Results:
- TLR3 influences the transcription and translation of cytokines, impacting cardiovascular cells.
- TLR3 dysregulation is implicated in vascular endothelial cell dysfunction and vascular smooth muscle cell proliferation.
- It plays a role in conditions like pulmonary arterial hypertension, atherosclerosis, myocardial infarction, and heart failure.
Conclusions:
- TLR3 is a significant mediator in the development and progression of cardiovascular diseases.
- Understanding TLR3's mechanisms offers potential for novel immunomodulatory therapeutic strategies.
- Further research is warranted for clinical translation of TLR3-targeted therapies.
More Related Videos
12:50Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
04:30Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Related Concept Videos
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Coronary Artery Disease II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease I: Introduction
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: